आईएसएसएन: 2155-9600
Fouad E. El hachimi*, Monica Medina Dobbs, Kim Lien Le
According to the CDC, Type II Diabetes Mellitus (T2D) patients are at increased risk of severe complications from COVID-19 pandemic 1 especially the elderly. T2D is increasing in the United States, with over 10% of the population is estimated to have T2D in 2018. The US population over the age of 65 have a much higher prevalence estimated at over 26%. This case report is about a successful reversal of early stage T2D in a 65 year old North African American male using only nutritional therapy guided by laboratory testing from his physician. After 6 weeks on the nutritional program the patient blood sugar normalized, and after three months his HbA1C went down from 6.9 to 5.4.